{"content":"<li class=\"n-box-item date-title\" data-end=\"1474430399\" data-start=\"1474344000\" data-txt=\"Sunday, December 22, 2019\">Tuesday, September 20, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3209977\" data-ts=\"1474427325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRT\" target=\"_blank\">CPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209977-copart-higher-on-q4-revenues-and-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Copart higher on Q4 revenues and earnings beat</a></h4><ul>\n<li>Copart (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CPRT\" title=\"Copart, Inc.\">CPRT</a>): FQ4 EPS of $0.59 <font color=\"green\">beats by $0.04</font>.</li>\n<li>Revenue of $332.7M (+17.9% Y/Y) <font color=\"green\">beats by $14.96M</font>.</li>\n<li>Shares <font color=\"green\">+4.1%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209977\" data-linked=\"Copart higher on Q4 revenues and earnings beat\" data-tweet=\"$CPRT - Copart higher on Q4 revenues and earnings beat https://seekingalpha.com/news/3209977-copart-higher-on-q4-revenues-and-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3209977-copart-higher-on-q4-revenues-and-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209970\" data-ts=\"1474411949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYBX\" target=\"_blank\">SYBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209970-mirna-stops-early-stage-study-of-lead-product-candidate-due-to-adverse-events-shares-off-29\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mirna stops early-stage study of lead product candidate due to adverse events; shares off 29% after hours</a></h4><ul>\n<li>Thinly traded nano cap Mirna Therapeutics (MIRN) slumps <font color=\"red\">29%</font> after hours on average volume in response to its announcement that it has voluntarily halted enrollment and dosing in its Phase 1 study of lead product candidate MRX34. The company made its decision after five immune-related severe adverse events were observed in patients dosed with MRX34.</li>\n<li>The company will also not be initiating a translational medicine study of MRX34 in melanoma patients, planned to start later this year.</li>\n<li>Mirna is continuing its analysis of the data and will discuss the situation with its advisors and FDA. Further updates will be released when appropriate.</li>\n<li>\n<a href=\"http://www.mirnatherapeutics.com/pipeline/mirna-MRX34.html\" target=\"_blank\">MRX34</a> is a double-stranded RNA mimic of the tumor suppressor microRNA, miR-34, incapsulated in a liposomal nanoparticle formulation called SMARTICLES.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209970\" data-linked=\"Mirna stops early-stage study of lead product candidate due to adverse events; shares off 29% after hours\" data-tweet=\"$SYBX - Mirna stops early-stage study of lead product candidate due to adverse events; shares off 29% after hours https://seekingalpha.com/news/3209970-mirna-stops-early-stage-study-of-lead-product-candidate-due-to-adverse-events-shares-off-29?source=tweet\" data-url=\"https://seekingalpha.com/news/3209970-mirna-stops-early-stage-study-of-lead-product-candidate-due-to-adverse-events-shares-off-29\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209968\" data-ts=\"1474410981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUS\" target=\"_blank\">NUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209968-nu-skin-settles-in-sec-probe-sees-q3-revenues-high-end-of-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nu Skin settles in SEC probe, sees Q3 revenues at high end of guidance</a></h4><ul>     <li>NuSkin (NYSE:<a href=\"https://seekingalpha.com/symbol/NUS\" title=\"Nu Skin Enterprises Inc.\">NUS</a>) <font color=\"green\">+3.6%</font> AH after disclosing that it <a href=\"https://seekingalpha.com/filing/3230360\" target=\"_blank\">reached an agreement with the SEC</a> to settle a probe into its charitable  contribution in China in 2013.</li>\n<li>NUS says it agreed to pay ~$765K after the SEC determined that its books and internal controls related to the donation were  insufficient.</li>\n<li>NUS also says it expects Q3 revenues will come in at  the high end of or slightly above its previous guidance of $560M-$580M vs. $581M analyst consensus estimate, citing the success of recent product introductions and favorable currency trends.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209968\" data-linked=\"Nu Skin settles in SEC probe, sees Q3 revenues at high end of guidance\" data-tweet=\"$NUS - Nu Skin settles in SEC probe, sees Q3 revenues at high end of guidance https://seekingalpha.com/news/3209968-nu-skin-settles-in-sec-probe-sees-q3-revenues-high-end-of-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3209968-nu-skin-settles-in-sec-probe-sees-q3-revenues-high-end-of-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209965\" data-ts=\"1474408648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGI\" target=\"_blank\">SBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209965-gray-television-sinks-withdraws-guidance-for-political-ad-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gray Television sinks, withdraws guidance for political ad revenue</a></h4><ul>   <li>Gray Television (<a href=\"https://seekingalpha.com/symbol/GTN\" title=\"Gray Television, Inc.\">GTN</a> <font color=\"red\">-9.4%</font>) has now withdrawn its guidance for political advertising revenue for Q3 and for Q4 -- the newest sign that spending oddities in the national races will have outsize effects on local broadcasters.</li>    <li>Overall Q3 net revenue, ex-political spending, should meet its previously issued guidance, however.</li>    <li>Political ad orders -- which have always been on shorter notice -- are arriving later than usual, Gray notes, and current orders are coming with just a few days' notice.</li>    <li>\"The Trump campaign and/or allied PACs have purchased advertising time in some Gray markets, and it has expressed interest in placing advertising in up to nine states involving up to 17 Gray markets,\" the company says. \"At this time, however, the campaign's future spending is currently impossible to predict.\"</li>    <li>The Clinton campaign and allied PACs are looking at ads in up to six states involving up to seven Gray markets.</li>    <li>While statewide races are tighter in Missouri, Indiana and North Carolina, Senate racesin Ohio and Colorado haven't led to \"robust\" spending as anticipated. And some big advertisers have indicated that they'll direct funds instead to organizing voters and other activities.</li>    <li>Sinclair Broadcast Group (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SBGI\" title=\"Sinclair Broadcast Group, Inc.\">SBGI</a>) also <font color=\"red\">tumbled 9.4%</font> today as it <a href=\"https://seekingalpha.com/news/3209785-sinclair-broadcast-minus-5_9-percent-cuts-political-revenue-forecast\" target=\"_blank\">cut its own forecast for political revenues</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209965\" data-linked=\"Gray Television sinks, withdraws guidance for political ad revenue\" data-tweet=\"$SBGI $SBGI $GTN - Gray Television sinks, withdraws guidance for political ad revenue https://seekingalpha.com/news/3209965-gray-television-sinks-withdraws-guidance-for-political-ad-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3209965-gray-television-sinks-withdraws-guidance-for-political-ad-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209963\" data-ts=\"1474407775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209963-leaked-page-may-tip-new-juicier-blackberry-dtek60\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leaked page may tip new, juicier BlackBerry DTEK60</a></h4><ul>   <li>The next phone from BlackBerry (<a href=\"https://seekingalpha.com/symbol/BBRY\" target=\"_blank\">BBRY</a> <font color=\"green\">+2.7%</font>) looks to be much more robust than the company's <a href=\"https://seekingalpha.com/news/3195961-blackberry-launches-second-android-powered-smartphone\" target=\"_blank\">second Android-based entry</a>, released in July -- at least according to a now-deleted page on the company's website.</li>    <li>The DTEK60, which <a href=\"http://crackberry.com/blackberry-argon-likely-be-released-dtek60\" target=\"_blank\">the site CrackBerry found</a> on a page that had \"donotpublish\" in its URL, could be the rumored \"Argon\" phone and a follow-up to the DTEK50 it put out this summer.</li>    <li>But it contains higher-powered specs than that phone, with a Qualcomm Snapdragon 820 64-bit quad-core processor, a 5.5\" screen with 2560 x 1440 Quad HD resolution, a 21-megapixel camera and 3,000 mAh battery, as well as a fingerprint sensor.</li>    <li>If released as described, the all-touch phone would leave another rumored model that brings back a physical keyboard for future days.</li>    <li>BBRY shares are <font color=\"green\">up 6.6%</font> since July 26.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3209963\" data-linked=\"Leaked page may tip new, juicier BlackBerry DTEK60\" data-tweet=\"$BB - Leaked page may tip new, juicier BlackBerry DTEK60 https://seekingalpha.com/news/3209963-leaked-page-may-tip-new-juicier-blackberry-dtek60?source=tweet\" data-url=\"https://seekingalpha.com/news/3209963-leaked-page-may-tip-new-juicier-blackberry-dtek60\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>120&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209961\" data-ts=\"1474407432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209961-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/CLVS\" title=\"Clovis Oncology\">CLVS</a> <font color=\"green\">+8.5%</font>. <a href=\"https://seekingalpha.com/symbol/ADBE\" title=\"Adobe Systems Incorporated\">ADBE</a> <font color=\"green\">+5.8%</font>. <a href=\"https://seekingalpha.com/symbol/ADMS\" title=\"Adamas Pharmaceuticals, Inc.\">ADMS</a> <font color=\"green\">+5.1%</font>. <a href=\"https://seekingalpha.com/symbol/NUS\" title=\"Nu Skin Enterprises Inc.\">NUS</a> <font color=\"green\">+3.6%</font>. <a href=\"https://seekingalpha.com/symbol/KBH\" title=\"KB Home\">KBH</a> <font color=\"green\">+3.3%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/ENIC\" title=\"Enel Chile SA Sponsored ADR\">ENIC</a> <font color=\"red\">-2.6%</font>. <a href=\"https://seekingalpha.com/symbol/SORL\" title=\"SORL Auto Parts, Inc.\">SORL</a> <font color=\"red\">-1.9%</font>. <a href=\"https://seekingalpha.com/symbol/CLLS\" title=\"Cellectis S.A.\">CLLS</a> <font color=\"red\">-1.5%</font>. <a href=\"https://seekingalpha.com/symbol/STM\" title=\"STMicroelectronics NV\">STM</a> <font color=\"red\">-1.3%</font>. EOCC <font color=\"red\">-1.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209961\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$CLVS $ADBE $ADMS - After Hours Gainers / Losers https://seekingalpha.com/news/3209961-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3209961-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209955\" data-ts=\"1474406087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVRA\" target=\"_blank\">SVRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209955-mast-therapeutics-phaseminus-3-trial-fails-shares-down-78-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mast Therapeutics phase-3 trial fails, shares down 78% AH</a></h4><ul>\n<li>Mast Therapeutics (MSTX) says phase-3 EPIC trial of vepoloxamer, which treats individuals with sickle cell disease experiencing vaso-occlusive crisis, did not meet its primary efficacy endpoint.</li>\n<li>Endpoint was  statistically significant reduction in the mean duration of VOC (82  hours in the vepoloxamer group compared to 78 hours in the placebo group  in the intent-to-treat population (p=0.09)). There were no statistically significant differences between treatment  groups in the intent-to-treat population across the two secondary  efficacy endpoints, rate of re-hospitalization for VOC and the  occurrence of acute chest syndrome.</li>\n<li>Company: \"We are exceedingly disappointed with these top-line results... These analyses are limited to just top-line data, so in the coming weeks  the Company intends to review the full data set from EPIC. In addition,  we plan to perform an interim analysis of the ongoing heart failure  trial of vepoloxamer.</li>\n<li>\"However, based on the data we've seen to date, we  expect we will terminate all clinical development of vepoloxamer.  Consequently, while we evaluate our options, we intend to significantly  and immediately reduce our operating expenses and continue our efforts  with AIR001, our lead asset in heart failure with preserved ejection  fraction, which currently is the subject of a 100-patient phase 2 study  expected to complete enrollment by the end of 2017.\"</li>\n<li>Conference call tomorrow, September 21, 2016, at 8:00 a.m. ET / 5:00 a.m. PT to discuss the results.</li>\n<li>Shares <font color=\"red\">-78%</font> to $0.13 AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209955\" data-linked=\"Mast Therapeutics phase-3 trial fails, shares down 78% AH\" data-tweet=\"$SVRA - Mast Therapeutics phase-3 trial fails, shares down 78% AH https://seekingalpha.com/news/3209955-mast-therapeutics-phaseminus-3-trial-fails-shares-down-78-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/3209955-mast-therapeutics-phaseminus-3-trial-fails-shares-down-78-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>86&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209942\" data-ts=\"1474405160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLVS\" target=\"_blank\">CLVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209942-janney-sees-many-suitors-for-clovis-shares-move-higher-again-in-post-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Janney sees many suitors for Clovis; shares move higher, again, in post market</a></h4><ul><li>Clovis (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a>) has always been considered an acquisition target with a &ldquo;long list&rdquo; of potential suitors including Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>), Merck &amp; Co. (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) , and Roche, Janney tells Bloomberg in an interview.</li><li>CEO Patrick Mahaffy has sold other companies including Pharmion, NeXstar Pharmaceuticals.</li><li>Clovis closed&nbsp;<font color='green'>+12.7%</font>&nbsp;and is up another&nbsp;<font color='green'>7.7%</font>&nbsp;AH. Earlier today the stock jumped when Gilead (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) said it is looking for cancer deals.</li><li>Clovis's PDUFA date &nbsp;for ovarian cancer drug rucaparib <a href=\"https://seekingalpha.com/news/3207635-ad-comm-meeting-ahead-fdas-action-date-clovis-rucaparib-shares-11-percent\" target=\"_blank\">is Feb. 23, 2017</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3209942\" data-linked=\"Janney sees many suitors for Clovis; shares move higher, again, in post market\" data-tweet=\"$CLVS $CLVS $LLY - Janney sees many suitors for Clovis; shares move higher, again, in post market https://seekingalpha.com/news/3209942-janney-sees-many-suitors-for-clovis-shares-move-higher-again-in-post-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3209942-janney-sees-many-suitors-for-clovis-shares-move-higher-again-in-post-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209941\" data-ts=\"1474405063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAFD\" target=\"_blank\">CAFD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209941-8point3-energy-to-buy-sunpowers-stake-in-henrietta-solar-project-for-134m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">8point3 Energy to buy Sunpower&#39;s stake in Henrietta solar project for $134M</a></h4><ul>\n<li>8point3 Energy Partners (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CAFD\" title=\"8point3 Energy Partners LP\">CAFD</a>) agrees to acquire SunPower's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a>) 49% stake in its 102 MW Henrietta Solar Project for $134M.</li>\n<li>CAFD expects the acquisition to generate ~$10.9M in annual cash distributions and has a 20-year contract life.</li>\n<li>The Henrietta project, located in California's San Luis Valley, will begin operations next month, and is majority owned by Southern Co. (NYSE:<a href=\"https://seekingalpha.com/symbol/SO\" title=\"Southern Company\">SO</a>)</li>\n<li>CAFD <font color=\"green\">+1.9%</font> AH, SPWR <font color=\"green\">+0.5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209941\" data-linked=\"8point3 Energy to buy Sunpower&#39;s stake in Henrietta solar project for $134M\" data-tweet=\"$CAFD $CAFD $SPWR - 8point3 Energy to buy Sunpower&#39;s stake in Henrietta solar project for $134M https://seekingalpha.com/news/3209941-8point3-energy-to-buy-sunpowers-stake-in-henrietta-solar-project-for-134m?source=tweet\" data-url=\"https://seekingalpha.com/news/3209941-8point3-energy-to-buy-sunpowers-stake-in-henrietta-solar-project-for-134m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209936\" data-ts=\"1474404222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209936-solid-results-for-fedex-tnt-express-in-mix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid results for FedEx with TNT Express in the mix</a></h4><ul>\n<li>FedEx (NYSE:<a href=\"https://seekingalpha.com/symbol/FDX\" title=\"FedEx Corporation\">FDX</a>) reports operating margin held steady at 9.3% in FQ1.</li>\n<li>Revenue growth by segment: Ground +12% to $4.29B, Freight +4% to $1.66B, Express +0.1% to $6.66B, TNT Express flat at $1.4B,</li>\n<li>Management says the TNT Express integration is \"proceeding smoothly\" and those costs came in line with expectations.</li>\n<li>The company sees adjusted FY17 EPS of $11.85 to $12.35 vs. $11.97 consensus. Capex spending of $5.6B is anticipated.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3209919-fedex-beats-0_12-beats-revenue\" target=\"_blank\">FedEx beats by $0.12, beats on revenue</a> (Sept. 20)</li>\n<li>FDX <font color=\"green\">+1.11%</font> AH to $164.45.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209936\" data-linked=\"Solid results for FedEx with TNT Express in the mix\" data-tweet=\"$FDX - Solid results for FedEx with TNT Express in the mix https://seekingalpha.com/news/3209936-solid-results-for-fedex-tnt-express-in-mix?source=tweet\" data-url=\"https://seekingalpha.com/news/3209936-solid-results-for-fedex-tnt-express-in-mix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209934\" data-ts=\"1474403929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209934-oil-on-move-api-shows-unexpected-decline-in-inventory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil on the move as API shows unexpected decline in inventory</a></h4><ul>\n<li>The numbers aren't yet available, but the API is reporting a sizable unexpected draw in oil inventories for the past week.</li>\n<li>Crude has added about $0.50 to earlier gains since the news hit, now <font color=\"green\">up 1.4% </font>on the session to $44.48 per barrel.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a> <font color=\"green\">+0.9%</font> after hours</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a>, <a href=\"https://seekingalpha.com/symbol/OIL\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/UWTI\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>, <a href=\"https://seekingalpha.com/symbol/UCO\" title=\"ProShares Ultra Bloomberg Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/DWTI\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>, <a href=\"https://seekingalpha.com/symbol/SCO\" title=\"ProShares UltraShort Bloomberg Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/BNO\" title=\"The United States Brent Oil ETF, LP\">BNO</a>, <a href=\"https://seekingalpha.com/symbol/DBO\" title=\"PowerShares DB Oil ETF\">DBO</a>, <a href=\"https://seekingalpha.com/symbol/DTO\" title=\"DB Crude Oil Double Short ETN\">DTO</a>, <a href=\"https://seekingalpha.com/symbol/UGA\" title=\"The United States Gasoline ETF, LP\">UGA</a>, <a href=\"https://seekingalpha.com/symbol/USL\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>, <a href=\"https://seekingalpha.com/symbol/DNO\" title=\"The United States Short Oil ETF, LP\">DNO</a>, <a href=\"https://seekingalpha.com/symbol/OLO\" title=\"DB Crude Oil Long ETN\">OLO</a>, <a href=\"https://seekingalpha.com/symbol/UHN\" title=\"The United States Diesel-Heating Oil ETF, LP\">UHN</a>, <a href=\"https://seekingalpha.com/symbol/SZO\" title=\"DB Crude Oil Short ETN\">SZO</a>, <a href=\"https://seekingalpha.com/symbol/OLEM\" title=\"iPath Pure Beta Crude Oil ETN\">OLEM</a>, <a href=\"https://seekingalpha.com/symbol/OILX\" title=\"Etracs S&amp;P GSCI Crude Oil Total Return Index ETN\">OILX</a>\n</li>\n<li>\n<a href=\"https://twitter.com/zerohedge/status/778332467929419779\" target=\"_blank\">Update at 4:40:</a> Crude oil draw of 7.5M barrels vs. a build of 1.4M last week. Gasoline draw of 2.5M barrels vs. a draw of 2.4M last week. Distillate build of 407K barrels vs. a draw of 1.1M last week.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209934\" data-linked=\"Oil on the move as API shows unexpected decline in inventory\" data-tweet=\"$USO $OIL $UWTI - Oil on the move as API shows unexpected decline in inventory https://seekingalpha.com/news/3209934-oil-on-move-api-shows-unexpected-decline-in-inventory?source=tweet\" data-url=\"https://seekingalpha.com/news/3209934-oil-on-move-api-shows-unexpected-decline-in-inventory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>62&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209926\" data-ts=\"1474403289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209926-kb-home-pops-higher-after-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Home pops higher after earnings beat</a></h4><ul>\n<li>FQ3 (ended Aug. 31) deliveries up 11% Y/Y to 2,487 homes, with particular strength in West Coast and Central regions. ASP up 2% to $365.9K.</li>\n<li>Adjusted housing gross profit margin up 10 basis points to 21.2%.</li>\n<li>Homebuilding operating income up 43% to $51.5M; operating margin up 120 basis pints to 6% (excl. inventory-related charges and prior year land sales).</li>\n<li>Ending backlog up 17% to $1.85B</li>\n<li>Net orders up 16% to 2,508; net order value up 20% to $929.6M.</li>\n<li>\n<a href=\"http://www.kbhome.com\" target=\"_blank\">Earnings call</a> at 5 ET</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3209911-kb-home-beats-0_03-misses-revenue\" target=\"_blank\">KB Home beats by $0.03, misses on revenue</a> (Sept. 20)</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/KBH\" title=\"KB Home\">KBH</a> <font color=\"green\">+6.5%</font> after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209926\" data-linked=\"KB Home pops higher after earnings beat\" data-tweet=\"$KBH - KB Home pops higher after earnings beat https://seekingalpha.com/news/3209926-kb-home-pops-higher-after-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3209926-kb-home-pops-higher-after-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209913\" data-ts=\"1474403169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209913-adobe-systems-exceeds-q3-estimates-provides-strong-guidanceplus-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adobe Systems exceeds Q3 estimates, provides strong guidance; +4% after hours</a></h4><ul>\n<li>Total revenue of $1.46B (+20% Y/Y), Digital Media segment revenue of $990M and Creative segment revenue of $803M (+39% Y/Y).</li>\n<li>Annualized recurring revenue of $3.7B ($285M Q/Q increase).</li>\n<li>Operating income increased 36% Y/Y, net income increased 37%.</li>\n<li>Cash flow from operations of $518M, deferred revenue of $1.8B.</li>\n<li>Approximately 3.5M shares repurchased, $344M returned to stockholders.</li>\n<li>Adobe (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ADBE\" title=\"Adobe Systems Incorporated\">ADBE</a>) president and CEO Shantanu Narayen: \"We drove strong revenue and earnings performance in Q3, further distancing ourselves from our competitors. Our leadership in cloud-based content and data platforms make us a mission critical partner to the world's biggest brands as they transform how they engage with their customers.\"</li>\n<li>Projects Q4 revenue of $1.55B-$1.6B, non-operating expense of $8M-$10M, tax rate of 21%, EPS of $0.83-$0.89 and share count of 503M-505M. Projects FY 2016 revenue of $5.8B-$5.85B, 20%+ Y/Y Digital Media segment revenue growth, Digital Media annualized recurring revenue of $4B, 20% Y/Y Adobe Marketing Cloud revenue growth, 30% Y/Y Adobe Market Cloud bookings growth and EPS of $2.94-$3.</li>\n<li><a href=\"https://asib.adobeconnect.com/adobeqec\" target=\"_blank\">Conference call</a></li>\n<li><a href=\"http://wwwimages.adobe.com/content/dam/Adobe/en/investor-relations/PDFs/02906102/qE5kMn0odE4s.pdf\" target=\"_blank\">Financial targets</a></li>\n<li><a href=\"http://wwwimages.adobe.com/content/dam/Adobe/en/investor-relations/PDFs/02906102/n39RyxaqrEm7.pdf\" target=\"_blank\">Data sheet</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209913\" data-linked=\"Adobe Systems exceeds Q3 estimates, provides strong guidance; +4% after hours\" data-tweet=\"$ADBE - Adobe Systems exceeds Q3 estimates, provides strong guidance; +4% after hours https://seekingalpha.com/news/3209913-adobe-systems-exceeds-q3-estimates-provides-strong-guidanceplus-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3209913-adobe-systems-exceeds-q3-estimates-provides-strong-guidanceplus-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209905\" data-ts=\"1474401465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNR\" target=\"_blank\">VNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209905-reuters-vanguard-natural-resources-hires-evercore-for-debt-reorganization\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Vanguard Natural Resources hires Evercore for debt reorganization</a></h4><ul>     <li>Vanguard Natural Resources (<a href=\"https://seekingalpha.com/symbol/VNR\" title=\"Vanguard Natural Resources, LLC\">VNR</a> <font color=\"red\">-2.8%</font>) has hired Evercore Partners to <a href=\"http://www.reuters.com/article/us-vnr-debt-idUSKCN11Q2JM\" target=\"_blank\">explore options for improving its finances</a> to help survive two years of weak energy prices, Reuters reports.</li>     <li>One of the options VNR is considering includes finding new financing to help pay down the company's debt, which totaled $1.8B as of June 30, including $1.4B drawn from its revolving credit facility, according to the report.</li>     <li>Earlier this year, VNR launched a debt swap in a bid to push out maturities and reduce interest expense, but the move did not attract much participation among the bondholders it targeted; VNR's bank lenders also gave it a loan  waiver in Q2.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209905\" data-linked=\"Reuters: Vanguard Natural Resources hires Evercore for debt reorganization\" data-tweet=\"$VNR - Reuters: Vanguard Natural Resources hires Evercore for debt reorganization https://seekingalpha.com/news/3209905-reuters-vanguard-natural-resources-hires-evercore-for-debt-reorganization?source=tweet\" data-url=\"https://seekingalpha.com/news/3209905-reuters-vanguard-natural-resources-hires-evercore-for-debt-reorganization\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209901\" data-ts=\"1474401254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209901-sarepta-prevails-over-biomarin-in-patent-fight-over-exon-skipping-shares-up-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta prevails over BioMarin in patent fight over exon skipping; shares up 13%</a></h4><ul>\n<li>The good news keeps coming for Sarepta Therapeutics (<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"green\">+13.2%</font>). Today the USPTO's Patent Trial and Appeals Board (PTAB) sided with Sarepta in its interference proceeding against BioMarin Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/BMRN\" title=\"BioMarin Pharmaceutical Inc.\">BMRN</a> <font color=\"green\">+0.1%</font>) related to patents covering \"exon skipping.\"</li>\n<li>A year ago, the PTAB<a href=\"https://seekingalpha.com/news/2803436-sarepta-losing-end-exon-51-skipping-patent-ruling-favor-biomarin-plans-appeal\" target=\"_blank\"> ruled in favor</a> of BioMarin's claims on the use of exon 51 antisense oligonucleotides to treat Duchenne muscular dystrophy (DMD) specified in its U.S. Patent Application No. 14/198,992, a decision Sarepta appealed. BioMarin licensed the patent from Academisch Ziekenhuis Leiden. The ruling included the cancellation of Sarepta's U.S. Patent No. 8,486,907, which Sarepta licensed from the University of Western Australia.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209901\" data-linked=\"Sarepta prevails over BioMarin in patent fight over exon skipping; shares up 13%\" data-tweet=\"$SRPT $SRPT $BMRN - Sarepta prevails over BioMarin in patent fight over exon skipping; shares up 13% https://seekingalpha.com/news/3209901-sarepta-prevails-over-biomarin-in-patent-fight-over-exon-skipping-shares-up-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3209901-sarepta-prevails-over-biomarin-in-patent-fight-over-exon-skipping-shares-up-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209900\" data-ts=\"1474401009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209900-moonves-no-worries-on-cbs-ads-funds-coming-to-buybacks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moonves: &#39;No worries&#39; on CBS ads; some funds coming to buybacks</a></h4><ul>   <li>Continuing his talk about the company's streaming service at the <a href=\"https://seekingalpha.com/news/3209896-cbs-chief-adjusting-streaming-fighting-churn-original-shows\" target=\"_blank\">Communacopia conference</a>, CBS (<a href=\"https://seekingalpha.com/symbol/CBS\" title=\"CBS Corporation\">CBS</a> <font color=\"red\">-2%</font>) chief Les Moonves says viewing of CBS All Access breaks down into three major groups.</li>    <li>The first and biggest is \"catch-up\" viewers seeing episodes from the current season they missed; that's about 65% of viewership. About 15-20% want \"old library\" shows from previous years, \"as recent as <i>CSI</i> or far back as <i>Cheers</i> or <i>I Love Lucy.\"</i>\n</li>    <li>About 10-15% want live streaming -- CBS All Access has deals with affiliates covering 95% of the country now -- but the configuration will begin to change with original programming that begins in about two weeks.</li>    <li>That has eventual implications for advertising, he notes. The ad scatter market \"looking forward is very strong,\" Moonves says, \"but almost not as relevant because it's the beginning of the year and the gun has gone off\"; scatter is much more relevant in the first and second quarters. Aside from the national political race, \"issue spending is tremendous\" in places like California and Pennsylvania. \"We have no worries.\"</li>    <li>\"To be paid just for [existing time-shifting measures] doesn't make sense anymore,\" he says. \"Poeple online are doing so much catch-up viewing, the ability to put advertising there just makes perfect sense ... As more time-shifting is going on, as people watch episodes later, and as we get more information [from measurement], dynamic ad insertion becomes a bigger part of what we are.\"</li>    <li>Capital coming in from the company's radio deal will be used in part for buybacks and part to invest back in the business. Investors always ask \"why didn't you buy back more; they're very fickle that way ... We're gonna continue with the same plan as we have.\"</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3209896-cbs-chief-adjusting-streaming-fighting-churn-original-shows\" target=\"_blank\">CBS chief: Adjusting to streaming; fighting churn with original shows</a> (Sep. 20 2016)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209900\" data-linked=\"Moonves: &#39;No worries&#39; on CBS ads; some funds coming to buybacks\" data-tweet=\"$CBS $VIAC - Moonves: &#39;No worries&#39; on CBS ads; some funds coming to buybacks https://seekingalpha.com/news/3209900-moonves-no-worries-on-cbs-ads-funds-coming-to-buybacks?source=tweet\" data-url=\"https://seekingalpha.com/news/3209900-moonves-no-worries-on-cbs-ads-funds-coming-to-buybacks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209898\" data-ts=\"1474400731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DO\" target=\"_blank\">DO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209898-diamond-offshore-upgraded-to-buy-evercore-amid-hope-for-offshore-rigs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diamond Offshore upgraded to Buy at Evercore amid hope for offshore rigs</a></h4><ul>     <li>Diamond Offshore (<a href=\"https://seekingalpha.com/symbol/DO\" title=\"Diamond Offshore Drilling Inc.\">DO</a> <font color=\"green\">+2.4%</font>) is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/09/20/offshore-drilling-why-new-rig-cancellations-might-be-good-news/\" target=\"_blank\">upgraded to Buy</a> from Hold at Evercore ISI, which believes the unwinding of shorts as oil prices firm and an offshore rig market bottom materializes over the next 6-12 months could be a catalyst for offshore drillers.</li>     <li>The firm notes the recent news that the Rowan Reliance drilling contract may be terminated early - the news was expected but was surprised that the company said an exclusive five-year service agreement could be in lieu of a contract termination; it sees the modified blend-and-extend agreement suggests the operator could see a potential offshore rig market bottoming by March 31 and tightening within the next 12 months.</li>     <li>Evercore continues to rate Ensco (<a href=\"https://seekingalpha.com/symbol/ESV\" title=\"Ensco PLC\">ESV</a> <font color=\"red\">-1.4%</font>), Rowan ([[RDC] <font color=\"red\">-0.5%</font>) and Noble Corp. (<a href=\"https://seekingalpha.com/symbol/NE\" title=\"Noble Corporation plc\">NE</a> <font color=\"red\">-2%</font>) as Buys, \"as this select group of offshore drillers will be survivors of the current multi-year cyclical downturn.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209898\" data-linked=\"Diamond Offshore upgraded to Buy at Evercore amid hope for offshore rigs\" data-tweet=\"$DO $DO $VAL - Diamond Offshore upgraded to Buy at Evercore amid hope for offshore rigs https://seekingalpha.com/news/3209898-diamond-offshore-upgraded-to-buy-evercore-amid-hope-for-offshore-rigs?source=tweet\" data-url=\"https://seekingalpha.com/news/3209898-diamond-offshore-upgraded-to-buy-evercore-amid-hope-for-offshore-rigs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209896\" data-ts=\"1474399928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209896-cbs-chief-adjusting-to-streaming-fighting-churn-original-shows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBS chief: Adjusting to streaming; fighting churn with original shows</a></h4><ul>   <li>Contrary to expectations, CBS (<a href=\"https://seekingalpha.com/symbol/CBS\" title=\"CBS Corporation\">CBS</a> <font color=\"red\">-1.5%</font>) is a big fan of Netflix, CEO Les Moonves says, and the service has made the programming world much more competitive.</li>    <li>\"We don't think they're eating the world; we don't think they're trying to put us out of business,\" Moonves said at the Goldman Sachs Communacopia Conference.</li>    <li>And its deals help with the network's launch of a new <i>Star Trek</i> series, appearing exclusively on CBS All Access at home: \"Netflix bought the entire universe, except for North America -- and they paid for the whole show ... I go to bed a lot happier at night knowing [the new] <i>Star Trek</i> is entirely paid for before it appears on our All Access service.\"</li>    <li>The Showtime over-the-top service that CBS launched will be able to stream worldwide the more original programming that CBS does, Moonves says. That's the key to fighting the churn inherent in streaming subs, he adds: On CBS All Access, an original <i>Big Brother</i> is coming up, followed by <i>The Good Wife</i> spin-off and <i>Star Trek: Discovery.</i>\n</li>\n<li>\"At Showtime, they've changed their schedule ... instead of two shows every quarter, there'll be a new show premiering almost every month,\" Moonves says. \"We expect that 1M subs on Showtime OTT to turn into 4M subs within a couple of years.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209896\" data-linked=\"CBS chief: Adjusting to streaming; fighting churn with original shows\" data-tweet=\"$CBS $VIAC - CBS chief: Adjusting to streaming; fighting churn with original shows https://seekingalpha.com/news/3209896-cbs-chief-adjusting-to-streaming-fighting-churn-original-shows?source=tweet\" data-url=\"https://seekingalpha.com/news/3209896-cbs-chief-adjusting-to-streaming-fighting-churn-original-shows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209890\" data-ts=\"1474399255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209890-gopro-realizing-worst-intraday-trading-levels-in-months-presentlyminus-7_65\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro realizing worst intraday trading levels in months, presently -7.65%</a></h4><ul>\n<li>Following a run-up as the company <a href=\"https://seekingalpha.com/news/3209592-gopro-plus-8-percent-unveils-hero-5-black-hero-5-session-karma\" target=\"_blank\">announced new products</a> yesterday and despite some <a href=\"https://seekingalpha.com/news/3209783-gopro-target-raised-goldman-sachs-subsequent-new-product-introductions\" target=\"_blank\">favorable commentary</a>, shares are trading sharply lower in today's session (at one point <font color=\"red\">lower by 11%</font>).</li>\n<li>GoPro supplier Ambarella (<a href=\"https://seekingalpha.com/symbol/AMBA\" title=\"Ambarella\">AMBA</a> <font color=\"red\">-2.9%</font>) is feeling the heat as well, trading at most <font color=\"red\">4% lower</font> during the day.</li>\n<li>On GoPro (<a href=\"https://seekingalpha.com/symbol/GPRO\" title=\"GoPro\">GPRO</a> <font color=\"red\">-7.6%</font>), analysts at J.P. Morgan (Paul Coster) and Wedbush Securities (Nick McKay) remain positive, while Stifel (Jim Duffy) and Piper Jaffray (Erinn Murphy) analysts rate the name at Hold and Underweight, respectively.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209890\" data-linked=\"GoPro realizing worst intraday trading levels in months, presently -7.65%\" data-tweet=\"$AMBA $AMBA $GPRO - GoPro realizing worst intraday trading levels in months, presently -7.65% https://seekingalpha.com/news/3209890-gopro-realizing-worst-intraday-trading-levels-in-months-presentlyminus-7_65?source=tweet\" data-url=\"https://seekingalpha.com/news/3209890-gopro-realizing-worst-intraday-trading-levels-in-months-presentlyminus-7_65\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209892\" data-ts=\"1474399241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAS\" target=\"_blank\">SEAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209892-post-ipo-low-for-seaworld-after-dividends-go-exile\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-IPO low for SeaWorld after dividends go into exile</a></h4><ul>     <li>Pulling the plug on a dividend payout isn't the type of thing that analysts and investors are likely to ignore.</li>     <li>Macquarie <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8477814/seaworld-shares-sink-on-dividend-suspension-macquarie-ca\" target=\"_blank\">sees</a> short-term selling pressure on SeaWorld Entertainment (<a href=\"https://seekingalpha.com/symbol/SEAS\" title=\"SeaWorld Entertainment Inc.\">SEAS</a> <font color=\"red\">-5.1%</font>), although it calls the action the right move. The firm lowers its estimate for second half EBITDA to $310M to $340M.</li>     <li>FBR Capital <a href=\"http://www.streetinsider.com/Analyst+Comments/SeaWorld+Entertainment+%28SEAS%29%3A+Dividend+Cut+Was+Telegraphed+-+FBR/12052665.html\" target=\"_blank\">notes</a> the dividend removal was well-telegraphed and sticks with a $15 price target on the theme park operator.</li>     <li>Janney Montgomery Scott isn't so kind in its assessment of the plan to buy back shares with the dividend funds. \"While a dividend cut is not a complete surprise, our view is that a portion of the money could be better spent reinvesting in the business and building new attractions,\" <a href=\"http://www.marketwatch.com/story/seaworlds-plan-to-use-dividend-money-to-buy-back-stock-is-a-bad-idea-2016-09-20?siteid=yhoof2\" target=\"_blank\">writes</a> analyst Tyler Batory.</li>\n<li>SeaWorld sunk to a post-IPO low of $11.77 earlier in the day. For those wondering, SeaWorld priced its IPO at $27 back in 2013.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209892\" data-linked=\"Post-IPO low for SeaWorld after dividends go into exile\" data-tweet=\"$SEAS - Post-IPO low for SeaWorld after dividends go into exile https://seekingalpha.com/news/3209892-post-ipo-low-for-seaworld-after-dividends-go-exile?source=tweet\" data-url=\"https://seekingalpha.com/news/3209892-post-ipo-low-for-seaworld-after-dividends-go-exile\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209891\" data-ts=\"1474399200\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TBRA\" target=\"_blank\">TBRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209891-h-c-wainwright-feeling-good-bullish-tobira-call-says-galectin-another-promising-nash-play\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H.C. Wainwright feeling good about bullish Tobira call, says Galectin another promising NASH play</a></h4><ul>\n<li>H.C. Wainwright analyst Ed Arce is doing a bit of chest thumping today after his bullish call on Tobira Therapeutics (<a href=\"https://seekingalpha.com/symbol/TBRA\" title=\"Tobira Therapeutics, Inc.\">TBRA</a> <font color=\"green\">+722.8%</font>) paid off in spades when Allergan (<a href=\"https://seekingalpha.com/symbol/AGN\" title=\"Allergan plc\">AGN</a> <font color=\"red\">-2.2%</font>) announced its intent to acquire the company for up to $1.7B. He raised his price target on the tiny biotech to $31 last month based his confidence that NASH candidate cenicriviroc will be successful in late-stage studies. TBRA shares plummeted to a low of $3.76 on August 2 after the company released the results from a failed mid-stage trial that used an endpoint that the company said will not be necessary to support regulatory applications. The trial met the endpoint that will be used in Phase 3 studies.</li>\n<li>In an interview with StreetInsider, Mr. Arce said he likes other players in the NASH space, specifically Galectin Therapeutics (<a href=\"https://seekingalpha.com/symbol/GALT\" title=\"Galectin Therapeutics, Inc.\">GALT</a> <font color=\"green\">+13.8%</font>), with top-line data from a mid-stage study of NASH candidate GR-MD-02 due this month, and Conatus Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/CNAT\" title=\"Conatus Pharmaceuticals\">CNAT</a> <font color=\"green\">+20.6%</font>), with lead candidate emricasan about to enter a Phase 2 trial using Exalenz Biosciences' BreathID Methacetin Breath Test to monitor patients during the study.</li>\n<li>\n<a href=\"http://galectintherapeutics.com/what-we-do/develop-proprietary-compounds-for-disease/development-program/\" target=\"_blank\">GR-MD-02</a> is a complex carbohydrate drug that targets <a href=\"https://en.wikipedia.org/wiki/Galectin-3\" target=\"_blank\">galectin-3</a>, a protein that plays a key role in the pathogenesis of fatty liver disease and fibrosis.</li>\n<li>\n<a href=\"http://www.conatuspharma.com/programs/mechanism-of-action.htm\" target=\"_blank\">Emricasan </a>inhibits a family of enzymes that modulate essential cellular functions called <a href=\"https://en.wikipedia.org/wiki/Caspase\" target=\"_blank\">caspases</a>. The functions include those involved in apoptosis and inflammation. Caspases 3 and 7 are major players in apoptosis. These enzymes cleave a key protein called <a href=\"https://biocare.net/wp-content/uploads/3061.pdf\" target=\"_blank\">CK18</a> (cytokeratin-18), part of which is the small fragment cCK18, which correlates to the magnitude of hepatocyte apoptosis. Emricasan inhibits apoptosis regardless of the stimuli that causes it.</li>\n<li>Mr. Arce has an $8 (315% upside) price target on GALT and $15 (608% upside) on CNAT, both rated Buy.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209891\" data-linked=\"H.C. Wainwright feeling good about bullish Tobira call, says Galectin another promising NASH play\" data-tweet=\"$TBRA $TBRA $AGN - H.C. Wainwright feeling good about bullish Tobira call, says Galectin another promising NASH play https://seekingalpha.com/news/3209891-h-c-wainwright-feeling-good-bullish-tobira-call-says-galectin-another-promising-nash-play?source=tweet\" data-url=\"https://seekingalpha.com/news/3209891-h-c-wainwright-feeling-good-bullish-tobira-call-says-galectin-another-promising-nash-play\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209886\" data-ts=\"1474398058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209886-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DTSI' title='DTS, Inc.'>DTSI</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/FNCX' title='Function&#40;x&#41; Inc.'>OTC:FNCX</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/AIRG' title='Airgain'>AIRG</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MGT' title='MGT Capital Investments Inc'>MGT</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/IQNT' title='Inteliquent, Inc.'>IQNT</a> <font color='red'>-9%</font>. MSDI <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209886\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$DTSI $FNCX $AIRG - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3209886-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3209886-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209885\" data-ts=\"1474397834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209885-sprint-t-mobile-claim-poaching-rivals-subscribers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint, T-Mobile claim they&#39;re poaching rival&#39;s subscribers</a></h4><ul>   <li>With wireless subscription growth slowing overall, the \"try harder\" guys each say they're stealing each other's customers.</li>    <li>T-Mobile (<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a> <font color=\"red\">-2.8%</font>) and Sprint (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"red\">-5.9%</font>) said today they're <a href=\"http://www.bloomberg.com/news/articles/2016-09-20/t-mobile-gains-753-000-monthly-subscribers-so-far-this-quarter?cmpid=yhoo.headline\" target=\"_blank\">taking subscribers from their small competitor</a>, and thus presenting a tougher challenge to industry leaders AT&amp;T and Verizon.</li>    <li>They can't both be 100% right, though time may tell. T-Mobile provided a preliminary update, while Sprint will release official results at the end of the quarter.</li>    <li>In its update, T-Mobile said it added about 753,000 branded postpaid phone subs in Q3 so far -- pacing below last year's Q3 gain of 1.1M with just a couple of weeks left, but ahead of Q2 in branded postpaid phone and prepaid net adds.</li>    <li>To be fair, T-Mobile (a standout in industry subscriber growth in recent quarters) says it's taking customers from everyone this quarter: 250,000 postpaid phone and prepaid net customer adds from Verizon (<a href=\"https://seekingalpha.com/symbol/VZ\" title=\"Verizon Communications\">VZ</a> <font color=\"green\">+0.3%</font>), and 400,000 from AT&amp;T (<a href=\"https://seekingalpha.com/symbol/T\" title=\"AT&amp;T Inc.\">T</a> <font color=\"red\">-0.1%</font>), to go along with 300,000 from Sprint.</li>    <li>T-Mobile will provide a business update in a presentation to Goldman Sachs' Communacopia Conference Thursday at 10:30 a.m. ET.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3209834-sprints-claure-employees-tied-turnaround-five-year-plan-track\" target=\"_blank\">Sprint's Claure: All employees tied to turnaround; Five-year plan on track</a> (Sep. 20 2016)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209885\" data-linked=\"Sprint, T-Mobile claim they&#39;re poaching rival&#39;s subscribers\" data-tweet=\"$TMUS $TMUS $S - Sprint, T-Mobile claim they&#39;re poaching rival&#39;s subscribers https://seekingalpha.com/news/3209885-sprint-t-mobile-claim-poaching-rivals-subscribers?source=tweet\" data-url=\"https://seekingalpha.com/news/3209885-sprint-t-mobile-claim-poaching-rivals-subscribers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>117&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209876\" data-ts=\"1474395460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGT\" target=\"_blank\">MGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209876-mgt-capital-investmentsminus-25-d-vasive-merger-denied-new-york-stock-exchange-listing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MGT Capital Investments -25%; D-Vasive merger denied New York Stock Exchange listing</a></h4><ul>\n<li>On news yesterday the company received a subpoena from the SEC requesting information, shares closed <font color=\"red\">around 20% lower</font>.</li>\n<li>Losses extend today as MGT Capital Investments (<a href=\"https://seekingalpha.com/symbol/MGT\" title=\"MGT Capital Investments Inc\">MGT</a> <font color=\"red\">-25%</font>) now updates investors on a planned merger with <a href=\"http://dvasive.com/\" target=\"_blank\">D-Vasive</a>, noting a required issuance of 43.8M shares to complete the deal has been denied listing.</li>\n<li>The company's management maintains the company is exploring alternatives, though investors so far aren't optimistic.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209876\" data-linked=\"MGT Capital Investments -25%; D-Vasive merger denied New York Stock Exchange listing\" data-tweet=\"$MGT - MGT Capital Investments -25%; D-Vasive merger denied New York Stock Exchange listing https://seekingalpha.com/news/3209876-mgt-capital-investmentsminus-25-d-vasive-merger-denied-new-york-stock-exchange-listing?source=tweet\" data-url=\"https://seekingalpha.com/news/3209876-mgt-capital-investmentsminus-25-d-vasive-merger-denied-new-york-stock-exchange-listing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209878\" data-ts=\"1474395416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECPG\" target=\"_blank\">ECPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209878-encore-capital-stung-citi-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Encore Capital stung by Citi downgrade</a></h4><ul>\n<li>\"CFPB debt collection rulemaking could prove more challenging than we anticipated,\" <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8477023/citi-moves-to-the-sidelines-on-encore-capital-as-cfpb-re\" target=\"_blank\">says analyst Michael Kaye</a>, quickly summing up the bear case on Encore Capital (<a href=\"https://seekingalpha.com/symbol/ECPG\" title=\"Encore Capital Group Inc\">ECPG</a> <font color=\"red\">-4.7%</font>).</li>\n<li>He downgrades from Buy to Neutral, but to Sell thanks to a cheap valuation (4.3x 2017 estimates) and improving fundamentals. The price target is cut to $24 from $31 (current is $21.50).</li>\n<li>\"We are starting to see early signs of a modest credit normalization which should benefit ECPG. However, we have yet to see the return of large sidelined card issuers and we wonder if they might not return until the CFPB rulemaking is finalizes.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209878\" data-linked=\"Encore Capital stung by Citi downgrade\" data-tweet=\"$ECPG - Encore Capital stung by Citi downgrade https://seekingalpha.com/news/3209878-encore-capital-stung-citi-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3209878-encore-capital-stung-citi-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209871\" data-ts=\"1474394430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209871-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/CLD\" title=\"Cloud Peak Energy, Inc.\">CLD</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/LTBR\" title=\"Lightbridge Corp\">LTBR</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/HGT-OLD\" title=\"Hugoton Royalty Trust\">HGT-OLD</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/SJT\" title=\"San Juan Basin Royalty Trust\">SJT</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/HNRG\" title=\"Hallador Energy Co\">HNRG</a> <font color=\"green\">+6%</font>.</li> <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/TANH\" title=\"Tantech Holdings\">TANH</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/SDPI\" title=\"Superior Drilling Products, Inc.\">SDPI</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/TDW\" title=\"Tidewater, Inc.\">TDW</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/CDXC\" title=\"ChromaDex Inc.\">CDXC</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/CVRR\" title=\"CVR Refining, LP\">CVRR</a> <font color=\"red\">-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3209871\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$CLDPQ $LTBR $HGT-OLD - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3209871-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3209871-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209975\" data-ts=\"1474394261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MUSA\" target=\"_blank\">MUSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209975-murphy-usa-to-suffer-near-term-hit-colonial-pipeline-shutdown-wells-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Murphy USA to suffer near-term hit by Colonial Pipeline shutdown, Wells says</a></h4><ul>     <li>Murphy USA (<a href=\"https://seekingalpha.com/symbol/MUSA\" title=\"Murphy USA, Inc.\">MUSA</a> <font color=\"red\">-3.8%</font>) likely will face near-term headwinds from the Colonial Pipeline shutdown, prompting a <a href=\"http://www.benzinga.com/node/8478362\" target=\"_blank\">2016 earnings warning</a> from analysts at Wells Fargo.</li>     <li>The firm expects the shutdown to hurt MUSA's FY 2016 EPS by $0.05-$0.15 given the neutralization of margin benefit from an increase in retail gas prices as stores are unable to get fuel; also, the inability of delivering fuel would hit MUSA's product supply and wholesale division.</li>     <li>Despite the near-term uncertainty around the Colonial Pipeline, Wells maintains its Outperform rating, as it continues to like MUSA's strong long-term outlook.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209975\" data-linked=\"Murphy USA to suffer near-term hit by Colonial Pipeline shutdown, Wells says\" data-tweet=\"$MUSA - Murphy USA to suffer near-term hit by Colonial Pipeline shutdown, Wells says https://seekingalpha.com/news/3209975-murphy-usa-to-suffer-near-term-hit-colonial-pipeline-shutdown-wells-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3209975-murphy-usa-to-suffer-near-term-hit-colonial-pipeline-shutdown-wells-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209853\" data-ts=\"1474390323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRUS\" target=\"_blank\">CRUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209853-cirrus-logics-iphone-content-increase-biometrics-technology-highlighted-in-canaccord-genuity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cirrus Logic&#39;s iPhone content increase, biometrics technology highlighted in Canaccord Genuity target raise</a></h4><ul>\n<li>Analyst Matthew Ramsay <a href=\"http://blogs.barrons.com/techtraderdaily/2016/09/20/cirrus-intel-gain-with-iphone-diversify-says-canaccord/\" target=\"_blank\">maintains</a> a Buy rating and raises his price target from $56 to $65 (current price $56.47).</li>\n<li>Ramsay notes Cirrus Logic's iPhone 7 chip content grew by 70% over the iPhone 6s with a dollar increase to $6 per phone up from $3.50.</li>\n<li>On biometrics prospects: \"We believe Cirrus\u2019 research into voice biometric security is gaining increasing interest from both smartphone OEMs and other consumer device makers. Discussion of this new technology came up in each meeting we hosted as an area of primary R&amp;D investment for the company with the possibility to integrate across the audio value chain (particularly with smart microphones) and drive more sticky and higher margin design wins for the company.\"</li>\n<li>Shares in Cirrus Logic (<a href=\"https://seekingalpha.com/symbol/CRUS\" title=\"Cirrus Logic, Inc.\">CRUS</a> <font color=\"green\">+1.7%</font>) are presently trading <font color=\"green\">up around 14%</font> from this point last week.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209853\" data-linked=\"Cirrus Logic&#39;s iPhone content increase, biometrics technology highlighted in Canaccord Genuity target raise\" data-tweet=\"$CRUS - Cirrus Logic&#39;s iPhone content increase, biometrics technology highlighted in Canaccord Genuity target raise https://seekingalpha.com/news/3209853-cirrus-logics-iphone-content-increase-biometrics-technology-highlighted-in-canaccord-genuity?source=tweet\" data-url=\"https://seekingalpha.com/news/3209853-cirrus-logics-iphone-content-increase-biometrics-technology-highlighted-in-canaccord-genuity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209852\" data-ts=\"1474389826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209852-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/BSPM\" title=\"Biostar Pharmaceutic\">OTC:BSPM</a> <font color=\"green\">+29%</font>. <a href=\"https://seekingalpha.com/symbol/GLMD\" title=\"Galmed Pharmaceuticals Ltd.\">GLMD</a> <font color=\"green\">+28%</font>. <a href=\"https://seekingalpha.com/symbol/DTSI\" title=\"DTS, Inc.\">DTSI</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/FNCX\" title=\"Function(x) Inc.\">OTC:FNCX</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/NAII\" title=\"Natural Alternatives International, Inc.\">NAII</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/CNAT\" title=\"Conatus Pharmaceuticals\">CNAT</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/ESPR\" title=\"Esperion Therapeutics\">ESPR</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/AMCN\" title=\"AirMedia Group Inc\">AMCN</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/GBSN-OLD\" title=\"Great Basin Scientific, Inc.\">GBSN</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/TRIL\" title=\"Trillium Therapeutics Inc.\">TRIL</a> <font color=\"green\">+13%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ASNA\" title=\"Ascena Retail Group Inc\">ASNA</a> <font color=\"red\">-28%</font>. <a href=\"https://seekingalpha.com/symbol/MGT\" title=\"MGT Capital Investments Inc\">MGT</a> <font color=\"red\">-23%</font>. <a href=\"https://seekingalpha.com/symbol/HNI\" title=\"HNI Corporation\">HNI</a> <font color=\"red\">-21%</font>. APPY <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/GTN\" title=\"Gray Television, Inc.\">GTN</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/SGOC\" title=\"SGOCO Techn\">SGOC</a> <font color=\"red\">-10%</font>. MSDI <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/MLSS\" title=\"Milestone Scientific Inc.\">MLSS</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/SBGI\" title=\"Sinclair Broadcast Group, Inc.\">SBGI</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/TLYS\" title=\"Tilly's, Inc.\">TLYS</a> <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209852\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$BSPM $GLMD $DTSI - Midday Gainers / Losers https://seekingalpha.com/news/3209852-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3209852-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209851\" data-ts=\"1474389705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209851-weak-farm-markets-mean-right-time-for-potash-merger-agrium-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak farm markets mean it&#39;s right time for Potash merger, Agrium CEO says</a></h4><ul>     <li>Weakness in the crop and fertilizer markets may not have hit rock bottom yet, meaning that <a href=\"http://www.reuters.com/article/us-agrium-m-a-potashcorp-idUSKCN11Q23U\" target=\"_blank\">now is the right time to merge</a> leading farm input suppliers, Agrium (AGU <font color=\"green\">+1.7%</font>) CEO Chuck Magro says in making a pitch to skeptical investors for a merger with Potash Corp. (POT <font color=\"green\">+0.7%</font>)</li>     <li>\"Are we at the bottom yet? We don't know. We  know there's more upside than downside. This is the time in the cycle where it makes sense to do mergers and acquisitions,\" Magro says.</li>     <li>The deal would combine POT's crop nutrient production capacity with AGU's farm retail network, and some AGU investors worry that the merger would leave them with greater exposure to the weak potash market.</li>     <li>U.S. prices of potash, urea and phosphate fertilizers, as well as corn and soybean values, are well below five- and 10-year averages, the two companies say in a joint presentation at a Scotiabank investor conference in Toronto.</li>     <li>Rival fertilizer producer Mosaic (<a href=\"https://seekingalpha.com/symbol/MOS\" title=\"The Mosaic Company\">MOS</a> <font color=\"green\">+0.3%</font>), which would be dwarfed by the merged AGU-POT, also is considering acquisition options, CFO Rich Mack says at the conference.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209851\" data-linked=\"Weak farm markets mean it&#39;s right time for Potash merger, Agrium CEO says\" data-tweet=\"$NTR $NTR $MOS - Weak farm markets mean it&#39;s right time for Potash merger, Agrium CEO says https://seekingalpha.com/news/3209851-weak-farm-markets-mean-right-time-for-potash-merger-agrium-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3209851-weak-farm-markets-mean-right-time-for-potash-merger-agrium-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209847\" data-ts=\"1474388701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEN\" target=\"_blank\">LEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209847-homebuilders-dip-after-lennar-results-slide-in-housing-starts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Homebuilders dip after Lennar results, slide in housing starts</a></h4><ul>\n<li>Lennar (NYSE:<a href=\"https://seekingalpha.com/symbol/LEN\" title=\"Lennar Corporation\">LEN</a>) was initially higher following <a href=\"https://seekingalpha.com/news/3209721-lennar-higher-strong-fq3-report\" target=\"_blank\">this morning's earnings beat</a>, but has turned<font color=\"red\"> lower by 4.3%</font> amid cautious earnings call comments on margins.</li>\n<li>Also at work is today's housing starts report which showed an unexpected sharp decline from July to August, with single-family starts <a href=\"https://seekingalpha.com/news/3209759-single-family-housing-starts-skid-10-month-low\" target=\"_blank\">dropping to a</a> 10-month low.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/ITB\" title=\"iShares U.S. Home Construction ETF\">ITB</a> <font color=\"red\">-1.4%</font>, <a href=\"https://seekingalpha.com/symbol/XHB\" title=\"SPDR Homebuilders ETF\">XHB</a><font color=\"red\"> -0.9%</font>\n</li>\n<li>Hovnanian (<a href=\"https://seekingalpha.com/symbol/HOV\" title=\"Hovnanian Enterprises, Inc.\">HOV</a> <font color=\"red\">-0.9%</font>), KB Home (<a href=\"https://seekingalpha.com/symbol/KBH\" title=\"KB Home\">KBH</a> <font color=\"red\">-1.4%</font>), Pulte (<a href=\"https://seekingalpha.com/symbol/PHM\" title=\"PulteGroup, Inc.\">PHM</a> <font color=\"red\">-3.2%</font>), D.R. Horton (<a href=\"https://seekingalpha.com/symbol/DHI\" title=\"D. R. Horton Inc.\">DHI</a> <font color=\"red\">-1.2%</font>), Toll Brothers (<a href=\"https://seekingalpha.com/symbol/TOL\" title=\"Toll Brothers Inc.\">TOL</a> <font color=\"red\">-1.4%</font>), Taylor Morrison (<a href=\"https://seekingalpha.com/symbol/TMHC\" title=\"Taylor Morrison\">TMHC</a> <font color=\"red\">-2.5%</font>), LGI Homes (<a href=\"https://seekingalpha.com/symbol/LGIH\" title=\"LGI Homes, Inc.\">LGIH</a> <font color=\"red\">-1.3%</font>)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209847\" data-linked=\"Homebuilders dip after Lennar results, slide in housing starts\" data-tweet=\"$LEN $LEN $ITB - Homebuilders dip after Lennar results, slide in housing starts https://seekingalpha.com/news/3209847-homebuilders-dip-after-lennar-results-slide-in-housing-starts?source=tweet\" data-url=\"https://seekingalpha.com/news/3209847-homebuilders-dip-after-lennar-results-slide-in-housing-starts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209846\" data-ts=\"1474388633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNM\" target=\"_blank\">PNM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209846-pnm-resources-upgraded-to-buy-from-hold-jefferies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PNM Resources upgraded to Buy from Hold at Jefferies</a></h4><ul>     <li>PNM Resources (<a href=\"https://seekingalpha.com/symbol/PNM\" title=\"PNM Resources, Inc.\">PNM</a> <font color=\"green\">+2%</font>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+PNM+Resources+%28PNM%29+to+Buy/12052611.html\" target=\"_blank\">upgraded to Buy</a> from Hold with a $37.50 price target, raised from $35, at Jefferies, which believes a final rate case decision from New Mexico regulators later this month will be more balanced than what is priced into the stock.</li>     <li>A negative hearing examiner recommendation was issued in August, and the firm believes a final order will prove more favorable.</li>     <li>Jefferies also downgrades American Electric Power (<a href=\"https://seekingalpha.com/symbol/AEP\" title=\"American Electric Power Company Inc\">AEP</a> <font color=\"red\">-0.2%</font>) to Hold from Buy.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209846\" data-linked=\"PNM Resources upgraded to Buy from Hold at Jefferies\" data-tweet=\"$PNM $PNM $AEP - PNM Resources upgraded to Buy from Hold at Jefferies https://seekingalpha.com/news/3209846-pnm-resources-upgraded-to-buy-from-hold-jefferies?source=tweet\" data-url=\"https://seekingalpha.com/news/3209846-pnm-resources-upgraded-to-buy-from-hold-jefferies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209844\" data-ts=\"1474387313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209844-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HNI' title='HNI Corporation'>HNI</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/BLBD' title='Blue Bird Corporation'>BLBD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/KNL' title='Knoll, Inc.'>KNL</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3209844\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$NVFY $HNI $BLBD - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3209844-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3209844-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209842\" data-ts=\"1474387058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTG\" target=\"_blank\">BTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209842-b2gold-upgraded-to-buy-dundee-on-upbeat-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">B2Gold upgraded to Buy at Dundee on upbeat guidance</a></h4><ul>     <li>B2Gold (<a href=\"https://seekingalpha.com/symbol/BTG\" title=\"B2Gold Corp.\">BTG</a> <font color=\"green\">+1.8%</font>) is <a href=\"http://business.financialpost.com/investing/trading-desk/b2gold-corp-upgraded-to-buy-at-dundee\" target=\"_blank\">upgraded to Buy</a> from Neutral with a C$4.50 price target, up from C$4.25, at Dundee Capital, after saying it expected to be at the top end of its 2016 production guidance and at the low end of expectations on costs.</li>\n<li>BTG's presentation at the Denver Gold Forum indicated the production should be at the top end of guidance of 510K-550K oz. in 2016, while costs should come in at the low end of guidance of $560-$595/oz.</li>\n<li>Dundee says it always has liked BTG's liquidity, leverage and low-cost profile; after offering its production profile, the firm says it also likes BTG's valuation.</li>     <li>The firm also notes that BTG's at-the-market equity offering provides an additional $100M, cleaning up any near-term balance sheet concerns.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209842\" data-linked=\"B2Gold upgraded to Buy at Dundee on upbeat guidance\" data-tweet=\"$BTG - B2Gold upgraded to Buy at Dundee on upbeat guidance https://seekingalpha.com/news/3209842-b2gold-upgraded-to-buy-dundee-on-upbeat-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3209842-b2gold-upgraded-to-buy-dundee-on-upbeat-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209839\" data-ts=\"1474385737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209839-petrobras-plans-to-exit-biofuels-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras plans to exit biofuels sector</a></h4><ul>     <li>Petrobras (<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petrobras - Petroleo Brasileiro S.A.\">PBR</a> <font color=\"green\">+3.2%</font>) says it plans to <a href=\"http://www.argusmedia.com/news/article/?id=1315500\" target=\"_blank\">completely exit biofuels production</a> as part of its <a href=\"https://seekingalpha.com/news/3209750-petrobras-cuts-planned-investments-25-percent-74b-five-years\" target=\"_blank\">2017-21 strategic plan</a>, after posted a net loss of 76M reais ($23.3M) in Q2.</li>     <li>The exit from biofuels is part of PBR's broader strategic plan  to exit non-strategic sectors such as gas  distribution, fertilizer production and stakes in some petrochemicals  assets.</li>\n<li>PBR runs three biodiesel plants in Brazil and owns minority stakes in seven sugar and ethanol mills; the company has the capacity to produce ~860M l/yr of  biodiesel and, like much of the industry in Brazil, much of it is  unused.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209839\" data-linked=\"Petrobras plans to exit biofuels sector\" data-tweet=\"$PBR - Petrobras plans to exit biofuels sector https://seekingalpha.com/news/3209839-petrobras-plans-to-exit-biofuels-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3209839-petrobras-plans-to-exit-biofuels-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209838\" data-ts=\"1474385730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209838-apparel-store-stock-follow-ascena-retail-group-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apparel store stock follow Ascena Retail Group lower</a></h4><ul>     <li>Apparel store stocks are trading soft after a brutal cut in guidance from Ascena Retail Group (<a href=\"https://seekingalpha.com/symbol/ASNA\" title=\"Ascena Retail Group Inc\">ASNA</a> <font color=\"red\">-26%</font>) cast a shadow over the group.</li>     <li>During Ascena's earnings call, CEO David Jaffe said a \"highly competitive selling environment\" and \"significant store traffic headwinds\" were tough to overcome.</li>\n<li>Former bulls FBR, Oppenheimer, and RBC Capital Market all abandoned their positive ratings on Ascena. While no Wall Street firms were out with a Sell rating on Ascena this summer in front of the earnings dud, SA contributor Terrier Investing issued a <a href=\"https://seekingalpha.com/article/3979388-ascena-retail-gross-margin-improvements-outrunning-woeful-comps\" target=\"_blank\">warning</a> in June.</li>     <li>Decliners today include Tilly's (<a href=\"https://seekingalpha.com/symbol/TLYS\" title=\"Tilly's, Inc.\">TLYS</a> <font color=\"red\">-8%</font>), Bebe Stores (<a href=\"https://seekingalpha.com/symbol/BEBE\" title=\"bebe stores, inc.\">OTC:BEBE</a> <font color=\"red\">-3.5%</font>), Stage Stores (<a href=\"https://seekingalpha.com/symbol/SSI\" title=\"Stage Stores, Inc.\">SSI</a> <font color=\"red\">-2%</font>), Express (<a href=\"https://seekingalpha.com/symbol/EXPR\" title=\"Express, Inc.\">EXPR</a> <font color=\"red\">-2.1%</font>), Chico's FAS (<a href=\"https://seekingalpha.com/symbol/CHS\" title=\"Chico's FAS, Inc.\">CHS</a> <font color=\"red\">-1.5%</font>), and Destination XL Group (<a href=\"https://seekingalpha.com/symbol/DXLG\" title=\"Destination XL Group, Inc.\">DXLG</a> <font color=\"red\">-1.7%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209838\" data-linked=\"Apparel store stock follow Ascena Retail Group lower\" data-tweet=\"$ASNA $ASNA $TLYS - Apparel store stock follow Ascena Retail Group lower https://seekingalpha.com/news/3209838-apparel-store-stock-follow-ascena-retail-group-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3209838-apparel-store-stock-follow-ascena-retail-group-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209803\" data-ts=\"1474383707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209803-healthcare-top-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top Gainers / Losers as of 11:00 am</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/BSPM\" title=\"Biostar Pharmaceutic\">OTC:BSPM</a> <font color=\"green\">+34%</font>. <a href=\"https://seekingalpha.com/symbol/GLMD\" title=\"Galmed Pharmaceuticals Ltd.\">GLMD</a> <font color=\"green\">+33%</font>. <a href=\"https://seekingalpha.com/symbol/CNAT\" title=\"Conatus Pharmaceuticals\">CNAT</a> <font color=\"green\">+25%</font>. <a href=\"https://seekingalpha.com/symbol/NAII\" title=\"Natural Alternatives International, Inc.\">NAII</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/ESPR\" title=\"Esperion Therapeutics\">ESPR</a> <font color=\"green\">+16%</font>.</li>\n<li>\n<b>Losers:</b> APPY <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/GEN\" title=\"Genesis Healthcare, Inc.\">GEN</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/NBY\" title=\"NovaBay Pharmaceuticals, Inc.\">NBY</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/SBOT\" title=\"Stellar Biotechnologies Inc.\">SBOT</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/CYH\" title=\"Community Health Systems, Inc.\">CYH</a> <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209803\" data-linked=\"Healthcare - Top Gainers / Losers as of 11:00 am\" data-tweet=\"$BSPM $GLMD $CNAT - Healthcare - Top Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3209803-healthcare-top-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3209803-healthcare-top-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209810\" data-ts=\"1474381813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAII\" target=\"_blank\">NAII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209810-natural-alternatives-fq4-top-line-up-58-net-income-up-247-shares-up-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural Alternatives FQ4 top line up 58%, net income up 247%; shares up 20%</a></h4><ul>\n<li>Thinly traded nano cap Natural Alternatives International (<a href=\"https://seekingalpha.com/symbol/NAII\" title=\"Natural Alternatives International, Inc.\">NAII</a> <font color=\"green\">+20.3%</font>) moves up on an 11x surge in volume in response to its release of fiscal Q4 and fiscal 2016 results.</li>\n<li>\n<strong>Fiscal Q4</strong> ($M): Net Sales: 35.7 (+58.0%); Net Income: 3.4 (+247.7%); EPS: 0.52 (+246.7%).</li>\n<li>\n<strong>Fiscal 2016</strong> ($M): Net Sales: 114.2 (+75.2%); Net Income: 9.5 (+185.3%); EPS: 1.44 (+193.9%).</li>\n<li>The company manufactures nutritional supplements and provides strategic partnering services to its customers.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209810\" data-linked=\"Natural Alternatives FQ4 top line up 58%, net income up 247%; shares up 20%\" data-tweet=\"$NAII - Natural Alternatives FQ4 top line up 58%, net income up 247%; shares up 20% https://seekingalpha.com/news/3209810-natural-alternatives-fq4-top-line-up-58-net-income-up-247-shares-up-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3209810-natural-alternatives-fq4-top-line-up-58-net-income-up-247-shares-up-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209805\" data-ts=\"1474380580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COLM\" target=\"_blank\">COLM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209805-columbia-sportswear-rallies-after-canaccord-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Columbia Sportswear rallies after Canaccord upgrade</a></h4><ul> <li>Shares of Columbia Sportswear (<a href=\"https://seekingalpha.com/symbol/COLM\" title=\"Columbia Sportswear Company\">COLM</a> <font color=\"green\">+3.3%</font>) move higher after Canaccord Genuity jumps in with an <a href=\"https://twitter.com/Briefingcom/status/778227433493319681\" target=\"_blank\">upgrade</a> to Buy from Hold.</li> <li>The investment firm also gives Columbia a generous price target boost to $72 from $59 (52-week high is $66.00).</li> <li>The bullish take on the apparel stock from Canaccord is based off its view that margins will recover in the back half of the year.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3209805\" data-linked=\"Columbia Sportswear rallies after Canaccord upgrade\" data-tweet=\"$COLM - Columbia Sportswear rallies after Canaccord upgrade https://seekingalpha.com/news/3209805-columbia-sportswear-rallies-after-canaccord-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3209805-columbia-sportswear-rallies-after-canaccord-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209795\" data-ts=\"1474379271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STM\" target=\"_blank\">STM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209795-arm-releases-chip-for-safety-critical-machine-processes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ARM releases chip for safety-critical machine processes</a></h4><ul>\n<li>The <a href=\"http://www.arm.com/products/processors/cortex-r/cortex-r52-processor.php\" target=\"_blank\">Cortex R-52</a> chip is designed for automotive, robotics, healthcare, farming, aviation, construction and other industry implementations.</li>\n<li>ARM VP of product marketing, <a href=\"http://www.bloomberg.com/news/articles/2016-09-19/arm-launches-new-chip-design-for-automotive-health-and-robotics\" target=\"_blank\">John Ronco</a>: \"You would want this anywhere there was a danger of loss of life or limb due to machine-human interaction.\"</li>\n<li>Development of the processor has been underway for five years and has already been <a href=\"http://www.reuters.com/article/us-arm-autos-processor-idUSKCN11Q1HB?feedType=RSS&amp;feedName=technologyNews\" target=\"_blank\">licensed</a> in a deal with French-Italian semiconductor manufacturer STMicroelectronics (<a href=\"https://seekingalpha.com/symbol/STM\" title=\"STMicroelectronics NV\">STM</a> <font color=\"green\">+1.5%</font>).</li>\n<li>The Cortex R-52 new chips are suggested to compete with Intel's (<a href=\"https://seekingalpha.com/symbol/INTC\" title=\"Intel Corporation\">INTC</a> <font color=\"red\">-0.1%</font>) <a href=\"https://newsroom.intel.com/editorials/blog-intel-acquires-yogitech-for-iot-functional-safety/\" target=\"_blank\">Yogitech</a> technology and further mark ARM's most significant design introduction since it was bought out by SoftBank (<a href=\"https://seekingalpha.com/symbol/SFTBY\" title=\"SoftBank Group ADR\">OTCPK:SFTBY</a> <font color=\"green\">+1.5%</font>) for $32B <a href=\"https://seekingalpha.com/news/3193627-softbank-buys-semiconductor-giant-arm-32b\" target=\"_blank\">back in July</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209795\" data-linked=\"ARM releases chip for safety-critical machine processes\" data-tweet=\"$STM $STM $INTC - ARM releases chip for safety-critical machine processes https://seekingalpha.com/news/3209795-arm-releases-chip-for-safety-critical-machine-processes?source=tweet\" data-url=\"https://seekingalpha.com/news/3209795-arm-releases-chip-for-safety-critical-machine-processes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209788\" data-ts=\"1474377946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209788-wells-fargo-higher-ahead-of-stumpf-testimony-morgan-stanley-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo higher ahead of Stumpf testimony as Morgan Stanley upgrades</a></h4><ul>\n<li>Another sell-sider buys the dip in Wells Fargo (NYSE:<a href=\"https://seekingalpha.com/symbol/WFC\" title=\"Wells Fargo &amp; Co.\">WFC</a>) as Morgan Stanley upgrades to Overweight from Equalweight, and lifts the price target to $56 from $53.</li>\n<li>The Senate Banking Committee show starts at 10 ET. <a href=\"https://www.c-span.org/video/?415547-1/ceo-john-stumpf-testifies-unauthorized-wells-fargo-accounts\" target=\"_blank\">Webcast here</a>. In prepared remarks, Stumpf says he takes full responsibility for the scandal, but says he's not going anywhere. Bloomberg's Matt Levine says there's a limit on how many times you ask a guy in a hearing \"this thing you did was pretty dumb,\" but look for the Senate to test that limit.</li>\n<li>Shares <font color=\"green\">+1.9</font>% premarket to $46.90.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209788\" data-linked=\"Wells Fargo higher ahead of Stumpf testimony as Morgan Stanley upgrades\" data-tweet=\"$WFC - Wells Fargo higher ahead of Stumpf testimony as Morgan Stanley upgrades https://seekingalpha.com/news/3209788-wells-fargo-higher-ahead-of-stumpf-testimony-morgan-stanley-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3209788-wells-fargo-higher-ahead-of-stumpf-testimony-morgan-stanley-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209785\" data-ts=\"1474377700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGI\" target=\"_blank\">SBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209785-sinclair-broadcastminus-5_9-cuts-political-revenue-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair Broadcast -5.9% as it cuts political revenue forecast</a></h4><ul>   <li>Sinclair Broadcast Group (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SBGI\" title=\"Sinclair Broadcast Group, Inc.\">SBGI</a>) is <font color=\"red\">5.9% lower</font> premarket after the company cut guidance on its Q3 media revenues, seeing a drop in political spending.</li>    <li>The company -- the nation's biggest local broadcaster -- now sees those revenues at around $637M-$638M (growth of about 28% Y/Y), down from previous guidance for $649.2M-$663.2M (growth of 30.3%-33.1%).</li>    <li>The lower forecast includes $46M of political spending vs. a previously expected $58M-$68M. \"Political is the most difficult part of our revenue to estimate given that advertising time is typically purchased with only a couple of days' notice prior to the ads airing,\" says Sinclair Chief Financial Officer Chris Ripley.</li>    <li>\"While we previously anticipated a decline in Presidential ad spending in the third quarter based on the late fundraising by the Trump campaign, we have yet to see significant spending, even at the levels we initially anticipated,\" he says in a statement. \"Additionally, our estimate is impacted by two other events, notably, a historically large political advertiser announced they were going to direct their funds to organizing voters rather than towards campaign funding.</li>    <li>\"Secondly, in Ohio, a key state for us and what was to be one of the most expensive Senate races in Ohio history, political spending has dropped drastically as recent polls reflect a widening margin between the Senatorial candidates,\" he adds. Recently, Republican Rob Portman has moved out to an advantage of around 13 percentage points against the Democrats' Ted Strickland.</li>    <li>While Q3 political ad revenue's revised down, he says Q3 core ad revenue estimates (low single-digit percent increase) is unchanged.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209785\" data-linked=\"Sinclair Broadcast -5.9% as it cuts political revenue forecast\" data-tweet=\"$SBGI - Sinclair Broadcast -5.9% as it cuts political revenue forecast https://seekingalpha.com/news/3209785-sinclair-broadcastminus-5_9-cuts-political-revenue-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3209785-sinclair-broadcastminus-5_9-cuts-political-revenue-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209784\" data-ts=\"1474377572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209784-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/DTSI' title='DTS, Inc.'>DTSI</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CCXI' title='ChemoCentryx'>CCXI</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/HNI' title='HNI Corporation'>HNI</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/MGT' title='MGT Capital Investments Inc'>MGT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SEAS' title='SeaWorld Entertainment Inc.'>SEAS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/EURN' title='Euronav NV'>EURN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ECA' title='Encana Corporation'>ECA</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3209784\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$CNAT $DTSI $GALT - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3209784-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3209784-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209783\" data-ts=\"1474377510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209783-gopro-target-raised-goldman-sachs-subsequent-new-product-introductions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro target raised at Goldman Sachs subsequent new product introductions</a></h4><ul>\n<li>Neutral rating <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8476232/gopros-karma-implications-goldman-sachs-sees-277-million\" target=\"_blank\">retained</a>.</li>\n<li>Price target now $14, up from $12.50 previously (current price $15.31).</li>\n<li>Analyst Simona Jankowski sees clean channel inventory exiting Q2 and views foreign language voice control features as strengthening international appeal. Further: \"The $399 HERO5 Black is $50 less than the previous high-end HERO4 Black and $100 less than its initial launch price, while still adding GPS, waterproofing (eliminating the case), video stabilization, and voice control. The new HERO5 Session fills in the mid-tier category at $299, with the original Session rounding out the good/better/best portfolio at $199.\"</li>\n<li>Citing a $2B drone market, she forecasts GoPro drone revenue of $31M for FY 2016 and $277M for FY 2017.</li>\n<li>GoPro (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GPRO\" title=\"GoPro\">GPRO</a>) <a href=\"https://seekingalpha.com/news/3209592-gopro-plus-8-percent-unveils-hero-5-black-hero-5-session-karma\" target=\"_blank\">announced</a> the Hero 5 Black, Hero 5 Session, Karma drone system and GoPro Plus subscription service at a launch event in California yesterday.</li>\n<li>Shares <font color=\"green\">+1%</font> pre-market.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209783\" data-linked=\"GoPro target raised at Goldman Sachs subsequent new product introductions\" data-tweet=\"$GPRO - GoPro target raised at Goldman Sachs subsequent new product introductions https://seekingalpha.com/news/3209783-gopro-target-raised-goldman-sachs-subsequent-new-product-introductions?source=tweet\" data-url=\"https://seekingalpha.com/news/3209783-gopro-target-raised-goldman-sachs-subsequent-new-product-introductions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209782\" data-ts=\"1474377441\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECA\" target=\"_blank\">ECA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209782-encana-prices-107m-share-offering-9_35-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Encana prices 107M-share offering at $9.35/share</a></h4><ul>     <li>Encana (NYSE:<a href=\"https://seekingalpha.com/symbol/ECA\" title=\"Encana Corporation\">ECA</a>) prices its 107M-share public offering at $9.35 per share, which would bring in $1B in gross proceeds; the over-allotment would attract anolther $150M.</li>     <li>The stock closed yesterday at $9.86 on the NYSE; the Toronto-listed shares closed at C$13.03.</li>     <li>ECA plans to use half the proceeds to help fund its 2017 capital spending, much of which will be in the Permian shale oil play in Texas, with the rest used to reduce debt, which has hovered slightly above industry norms.</li>     <li>ECA <font color=\"red\">-6%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209782\" data-linked=\"Encana prices 107M-share offering at $9.35/share\" data-tweet=\"$ECA - Encana prices 107M-share offering at $9.35/share https://seekingalpha.com/news/3209782-encana-prices-107m-share-offering-9_35-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3209782-encana-prices-107m-share-offering-9_35-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209765\" data-ts=\"1474375971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209765-allergans-tobira-takeover-stokes-nash-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan&#39;s Tobira takeover stokes NASH stocks</a></h4><ul>\n<li>Once investors catch their collective breath over Allergan's (NYSE:<a href=\"https://seekingalpha.com/symbol/AGN\" title=\"Allergan plc\">AGN</a>) wildly bullish takeout of Tobira Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TBRA\" title=\"Tobira Therapeutics, Inc.\">TBRA</a>), they may want to keep an eye on other NASH players. Some, of course, have more credibility than others.</li>\n<li>Premarket movers: MediciNova (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MNOV\" title=\"MediciNova, Inc.\">MNOV</a>) <font color=\"green\">+3.3%</font>; Regulus Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RGLS\" title=\"Regulus Therapeutics\">RGLS</a>) <font color=\"green\">+3.1%</font>; Intercept Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ICPT\" title=\"Intercept Pharmaceuticals\">ICPT</a>) <font color=\"green\">+6.0%</font>; Conatus Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CNAT\" title=\"Conatus Pharmaceuticals\">CNAT</a>) <font color=\"green\">+38.3%</font>; Galectin Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GALT\" title=\"Galectin Therapeutics, Inc.\">GALT</a>) <font color=\"green\">+24.0%</font>; Shire plc (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SHPG\" title=\"Shire PLC\">SHPG</a>): <font color=\"green\">+1.0%</font>; Can-Fite BioPharma (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/CANF\" title=\"Can-Fite Biopharma Ltd\">CANF</a>) <font color=\"green\">+23.1%</font>.</li>\n<li>Others: Galmed Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GLMD\" title=\"Galmed Pharmaceuticals Ltd.\">GLMD</a>); Vascular Biogenics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VBLT\" title=\"VBL Therapeutics\">VBLT</a>); Islet Sciences (<a href=\"https://seekingalpha.com/symbol/ISLT\" title=\"Islet Sciences, Inc.\">OTC:ISLT</a>); Genfit (<a href=\"https://seekingalpha.com/symbol/GNFTF\" title=\"Genfit\">OTCPK:GNFTF</a>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209765\" data-linked=\"Allergan&#39;s Tobira takeover stokes NASH stocks\" data-tweet=\"$AGN $AGN $TBRA - Allergan&#39;s Tobira takeover stokes NASH stocks https://seekingalpha.com/news/3209765-allergans-tobira-takeover-stokes-nash-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3209765-allergans-tobira-takeover-stokes-nash-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209764\" data-ts=\"1474375793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIR\" target=\"_blank\">PIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209764-pier-1-imports-hears-from-hedge-fund-stakeholder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pier 1 Imports hears from hedge fund stakeholder</a></h4><ul> <li>Alden Global Capital holds a 9.5% stake in Pier 1 Imports (NYSE:<a href=\"https://seekingalpha.com/symbol/PIR\" title=\"Pier 1 Imports Inc.\">PIR</a>), according to a fresh SEC filing.</li> <li>The hedge fund says it has already talked to Pier 1 about operational performance and board representation.</li> <li><a href=\"https://seekingalpha.com/filing/3229220\" target=\"_blank\">SEC Form 13D</a></li> <li>Shares of Pier 1 Imports are <font color=\"green\">up 5.12%</font> premarket to $4.31.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3209764\" data-linked=\"Pier 1 Imports hears from hedge fund stakeholder\" data-tweet=\"$PIR - Pier 1 Imports hears from hedge fund stakeholder https://seekingalpha.com/news/3209764-pier-1-imports-hears-from-hedge-fund-stakeholder?source=tweet\" data-url=\"https://seekingalpha.com/news/3209764-pier-1-imports-hears-from-hedge-fund-stakeholder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209761\" data-ts=\"1474375395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNI\" target=\"_blank\">HNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209761-hni-corporation-slides-after-lowering-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HNI Corporation slides after lowering guidance</a></h4><ul> <li>HNI Corporation (NYSE:<a href=\"https://seekingalpha.com/symbol/HNI\" title=\"HNI Corporation\">HNI</a>) reduces Q3 and FY16 guidance after warning that demand in the office furniture and hearth segments is weaker than anticipated.</li> <li>\"Sales for the quarter did not develop as expected.  Economic uncertainty is weighing on our markets making them more dynamic and difficult to predict than recent periods,\" says HNI.</li> <li>Raymond James <a href=\"http://www.streetinsider.com/Downgrades/Raymond+James+Downgrades+HNI+Corp+%28HNI%29+to+Market+Perform/12053231.html\" target=\"_blank\">lowers</a> its rating on HNI to Market Perform from Outperform after factoring in the guidance cut.</li> <li>Shares of HNI are <font color=\"red\">down 13.60%</font> premarket to $46.84.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3209761\" data-linked=\"HNI Corporation slides after lowering guidance\" data-tweet=\"$HNI - HNI Corporation slides after lowering guidance https://seekingalpha.com/news/3209761-hni-corporation-slides-after-lowering-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3209761-hni-corporation-slides-after-lowering-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209759\" data-ts=\"1474375310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209759-single-family-housing-starts-skid-to-10-month-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Single-family housing starts skid to 10-month low</a></h4><ul>\n<li>Economists had expected just a modest decline in housing starts in August, but <a href=\"https://seekingalpha.com/news/3209753-housing-starts-unexpectedly-tumble\" target=\"_blank\">the number unexpectedly</a> fell a full 5.8% to a seasonally-adjusted annualized rate of 1.142M. Single-family starts fell 6% to a 10-month low of 722K.</li>\n<li>Building permits slid only a hair in August to 1.139M, though that pace is 2.3% below that of one year ago.</li>\n<li>Checking regions, housing starts rose modestly in the Northeast, Midwest, and West, but they fell to 543K from 637K in the South.</li>\n<li>One wonders if it's the supply constraints builders keep talking about, rather than slacking demand.</li>\n<li><a href=\"http://www.census.gov/construction/nrc/pdf/newresconst.pdf\" target=\"_blank\">Full report</a></li>\n<li>Bond prices initially jumped on the weak print, but have given back those gains, with the 10-year Treasury returned to where it was ahead of the number - down 2.5 basis points to 1.688%. <a href=\"https://seekingalpha.com/symbol/TLT\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a> <font color=\"green\">+0.5%</font>, <a href=\"https://seekingalpha.com/symbol/TBT\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a> <font color=\"red\">-1%</font>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209759\" data-linked=\"Single-family housing starts skid to 10-month low\" data-tweet=\"$TLT $TBT - Single-family housing starts skid to 10-month low https://seekingalpha.com/news/3209759-single-family-housing-starts-skid-to-10-month-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3209759-single-family-housing-starts-skid-to-10-month-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>63&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209752\" data-ts=\"1474374202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209752-allergan-takes-out-tobira-for-28_35-and-up-to-49_84-in-cvrs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan takes out Tobira for $28.35 and up to $49.84 in CVRs</a></h4><ul>\n<li>Allergan (NYSE:<a href=\"https://seekingalpha.com/symbol/AGN\" title=\"Allergan plc\">AGN</a>) inks an <a href=\"http://finance.yahoo.com/news/allergan-acquire-tobira-therapeutics-expanding-120000171.html\" target=\"_blank\">agreement </a>to acquire nano cap Tobira Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TBRA\" title=\"Tobira Therapeutics, Inc.\">TBRA</a>) for $28.35 in upfront cash, a whopping six-fold premium to yesterday's close of $4.74. The potential consideration paid to TBRA shareholders could rise to $1.695B based on the successful completion of certain milestones [up to $49.84 in Contingent Value Rights (CVRs)] related to Tobira's lead product candidate cenicriviroc, in development for the treatment of non-alcoholic steatohepatitis (NASH).</li>\n<li>The extraordinary premium is even more surprising considering the failure of cenicriviroc in an earlier NASH study, although the company said the primary endpoint would not be required to support a marketing application. Allergan clearly agrees.</li>\n<li>\n<a href=\"http://www.tobiratherapeutics.com/pipeline/cvc-for-nash/\" target=\"_blank\">Cenicriviroc</a> is a dual inhibitor of proteins called <a href=\"http://en.wikipedia.org/wiki/CCR2\" target=\"_blank\">CCR2 </a>and <a href=\"http://en.wikipedia.org/wiki/CCR5\" target=\"_blank\">CCR5</a> that play key roles in inflammation and fibrosis.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3195425-tobiras-lead-product-candidate-flunks-mid-stage-nash-study-shares-plummet-54-percent\" target=\"_blank\">Tobira's lead product candidate flunks mid-stage NASH study; shares plummet 54% premarket</a> (July 25)</li>\n<li>\n<a href=\"https://www.sec.gov/Archives/edgar/data/920148/000092014816000232/ex99192016pr.htm\" target=\"_blank\">Update</a>: Allergan will host a <a href=\"https://www.sec.gov/Archives/edgar/data/1578845/000119312516714162/d248177dex991.htm\" target=\"_blank\">conference call</a> tomorrow, September 21, at 8:30 am ET to discuss the transaction and other recent R&amp;D acquisitions.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209752\" data-linked=\"Allergan takes out Tobira for $28.35 and up to $49.84 in CVRs\" data-tweet=\"$AGN $AGN $TBRA - Allergan takes out Tobira for $28.35 and up to $49.84 in CVRs https://seekingalpha.com/news/3209752-allergan-takes-out-tobira-for-28_35-and-up-to-49_84-in-cvrs?source=tweet\" data-url=\"https://seekingalpha.com/news/3209752-allergan-takes-out-tobira-for-28_35-and-up-to-49_84-in-cvrs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209743\" data-ts=\"1474372978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TBRA\" target=\"_blank\">TBRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209743-trading-in-tobira-therapeutics-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading in Tobira Therapeutics halted pending news</a></h4><ul>\n<li>NASDAQ has suspended trading in Tobira Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TBRA\" title=\"Tobira Therapeutics, Inc.\">TBRA</a>) pending the release of news.</li>\n<li>Shares have yet to recover from a plunge in July after lead product candidate cenicriviroc failed a mid-stage study in NASH.</li>\n<li>\n<strong>Update</strong>: Allergan (NYSE:<a href=\"https://seekingalpha.com/symbol/AGN\" title=\"Allergan plc\">AGN</a>) to acquire for $28.35 a share.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209743\" data-linked=\"Trading in Tobira Therapeutics halted pending news\" data-tweet=\"$TBRA $TBRA $AGN - Trading in Tobira Therapeutics halted pending news https://seekingalpha.com/news/3209743-trading-in-tobira-therapeutics-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3209743-trading-in-tobira-therapeutics-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209721\" data-ts=\"1474370162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEN\" target=\"_blank\">LEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209721-lennar-higher-after-strong-fq3-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lennar higher after strong FQ3 report</a></h4><ul>\n<li>FQ3 net earnings of $235.8M or $1.01 per share vs. $223.3M and $0.96 one year ago.</li>\n<li>Deliveries up 7% Y/Y to 6,779 homes.</li>\n<li>New orders up 8% in count to 7,018, up 10% in dollar value to $2.6B.</li>\n<li>Backlogs up 12% in count to 9,253; up 14% in dollar value to $3.4B.</li>\n<li>Gross margin of 22.6% down 150 basis points; operating margin of 13.2% down 90 basis points.</li>\n<li>Lennar Financial Services operating earnings of $53.2M up from $39.4M.</li>\n<li>\n<a href=\"http://www.lennar.com\" target=\"_blank\">Conference call</a> at 11 ET</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3209705-lennar-reports-fq3-results\" target=\"_blank\">Lennar reports FQ3 results</a> (Sept. 20)</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/LEN\" title=\"Lennar Corporation\">LEN</a> +2.75% premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209721\" data-linked=\"Lennar higher after strong FQ3 report\" data-tweet=\"$LEN - Lennar higher after strong FQ3 report https://seekingalpha.com/news/3209721-lennar-higher-after-strong-fq3-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3209721-lennar-higher-after-strong-fq3-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209718\" data-ts=\"1474369794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTSI\" target=\"_blank\">DTSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209718-tessera-to-acquire-dts-in-850m-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tessera to acquire DTS in $850M deal</a></h4><ul>\n<li>The all-cash deal is for $42.50 per share, <font color=\"green\">27% above</font> <a href=\"https://seekingalpha.com/symbol/DTSI\" title=\"DTS, Inc.\">DTSI</a>'s close last night.</li>\n<li>The purchase is expected to be immediately accretive to Tessera's (TSRA) EPS, with the combined company slated to realize $15M in annual cost synergies within the first 12-18 months following the close.</li>\n<li>A <a href=\"http://www.tessera.com\" target=\"_blank\">conference call</a> is set for 8:30 ET.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209718\" data-linked=\"Tessera to acquire DTS in $850M deal\" data-tweet=\"$DTSI $DTSI $XPER - Tessera to acquire DTS in $850M deal https://seekingalpha.com/news/3209718-tessera-to-acquire-dts-in-850m-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3209718-tessera-to-acquire-dts-in-850m-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3209691\" data-ts=\"1474353545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TKTDQ\" target=\"_blank\">TKTDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3209691-takata-tanks-bidders-mull-bankruptcy-option\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Takata tanks as bidders mull bankruptcy option</a></h4><ul>\n<li>Takata (TKTDY) shares <font color=\"red\">fell 12%</font> in Tokyo as bidders for the company were said to consider the possibility of some form of bankruptcy proceedings for the air bag maker behind the auto industry's biggest ever safety recall.</li>\n<li>Suitors have been asked to submit their proposals by early this week, and include Carlyle (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CG\" title=\"The Carlyle Group\">CG</a>), Daicel Corp. and <a href=\"https://seekingalpha.com/symbol/KKR\" title=\"KKR\">KKR</a>, <a href=\"http://www.bloomberg.com/news/articles/2016-09-20/takata-shares-fall-bidders-said-to-mull-bankruptcy-possibility\" target=\"_blank\">sources told Bloomberg</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3209691\" data-linked=\"Takata tanks as bidders mull bankruptcy option\" data-tweet=\"$TKTDQ $TKTDQ $CG - Takata tanks as bidders mull bankruptcy option https://seekingalpha.com/news/3209691-takata-tanks-bidders-mull-bankruptcy-option?source=tweet\" data-url=\"https://seekingalpha.com/news/3209691-takata-tanks-bidders-mull-bankruptcy-option\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":54,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}